ŻELAZNY, P.; FILIPCZAK, J.; SYGACZ, O.; BRÓŻ, S.; DANKIEWICZ, S.; SWORA, A.; BOROWIK, J.; BRODOWSKI, W.; PAWŁOWSKI, P.; BASTA-ARCISZEWSKA, K. Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF). Journal of Education, Health and Sport, [S. l.], v. 12, n. 9, p. 583–588, 2022. DOI: 10.12775/JEHS.2022.12.09.068. Disponível em: https://apcz.umk.pl/JEHS/article/view/39770. Acesso em: 24 apr. 2024.